Search

You searched for "musical"

2377 results found

In conversation with De Wet Swanepoel

1 November 2017 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric
A revolutionary new otoscope is using artificial intelligence to dramatically improve access to ear and hearing care in South African outreach communities. Carolina Leal, spoke to Professor De Wet Swanepoel of the University of Pretoria about how his team developed...

Diagnosis and treatment of snoring in adults – S2k Guideline of the German Society of Otorhinolaryngology, Head and Neck Surgery

1 May 2015 |
This article summarises the work done by the German Society of Otorhinolaryngology, who have developed guidelines for the management of snoring. ‘S2k’ is German nomenclature for a consensus based guideline, which (for those of you interested in such things), is...

Cochlear implantation in Tanzania: the journey and the outcomes

1 July 2021 | | ENTA - Auditory Implants, ENTA - ENT, ENTA - Otology
It is estimated that over 400 million people worldwide live with disabling hearing loss, 39.9 million of whom live in sub-Saharan Africa [1]. This article by Dr Aveline Kahinga and Mr Ali Jaffer demonstrates the effort that has been made...

In conversation with Professor Gerry O’Donoghue

14 August 2025 | | ENTA - General, ENTA - Auditory Implants
On the occasion of his retirement from the Nottingham Auditory Implant Programme, we discuss his pioneering work in cochlear implantation and the challenges involved. ENT News author picture, 1993. Why did you choose a career in ENT? I started off...
ALLERGY cover

CRSwNP, another monoclonal antibody

1 July 2019 | | ENTA - Rhinology / Sinus | biomarkers, dupilumab, nasal polyposis, nasal secretions, type 2 inflammation
Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...
Otolaryngologic Clinics journal image.

Biologics for deafness

5 July 2022 | | ENTA - Otology
Cochlear implants and hearing aids are inherently limited in their ability to restore ‘natural’ hearing. Biological therapy to treat inner ear pathology still is evolving rapidly with several ongoing clinical trials, though none are available for clinical practice to date....

BAHNO 2025

16 May 2025 | ENTA - Head & Neck
From groundbreaking research to a debate on the centralisation of head and neck services, BAHNO provided a wide ranging and clinically enriching programme for all those involved in head and neck oncology care.

BSO Annual Meeting & Juniors Day

14 March 2024 -15 March 2024 | ENTA - ENT
Irene Benaran (left), ENT CDF and Noah Evans Harding (right), ENT ST4, University Hospital Monklands, Lanarkshire, UK. The theme of this year's British Society of Otology (BSO) annual meeting was ‘The Past, Present and Future of Otology’. To introduce aspiring...

Congenital CMV: investigations and management in the audiology setting

1 July 2017 | | ENTA - Audiology - Paediatric, ENTA - Audiology - Diagnostic, ENTA - Vestibular Disorders
Congenital cytomegalovirus (cCMV) is the only cause of congenital sensorineural hearing loss (SNHL) for which there is a medical treatment available to prevent further hearing loss. Dr Simone Walter discusses cCMV infection, cCMV-related hearing loss, and how to facilitate their...

Sugammadex

1 November 2019 | | ENTA - ENT
Scott Russell is an anaesthetist with an almost unrivalled experience of complex head and neck surgery, and has seen all manner of new ideas come and go. However, in this article he describes a new pharmaceutical agent that is already...

Rhinoplasty: state-of-the-art

1 May 2017 | | ENTA - ENT, ENTA - Rhinoplasty
Rhinoplasty surgery has evolved over the years, and Pietro Palma introduces a further new concept. When flicking through the topics of major rhinoplasty meetings, the astute observer will realise that, at present, there are two mainstream schools of rhinoplasty, which...

Robotic surgery for squamous cell cancer: the new frontiers

4 November 2021 | | ENTA - Head & Neck
Although the da Vinci platform was FDA approved for early-stage oropharyngeal cancers, the indications have expanded. In this article, John Hardman explains how surgeons, with greater understanding of the strengths and limitations of robotic surgery, have systematically set out to...